|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/4439 | (2006.01) |
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 3388064 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18173541.6 |
| Date of filing the European patent application | 2015-04-01 | |
| (97) | Date of publication of the European application | 2018-10-17 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-10 |
| (46) | Date of publication of the claims translation | 2021-05-25 |
| (30) | Number | Date | Country code |
| 14382130 | 2014-04-02 | EP |
| (72) |
GARCIA COLLAZO, Ana Maria, ES
ECKLAND, David John Augustus, GB
PIZCUETA LALANZA, Maria Pilar, ES
MARTINELL PEDEMONTE, Marc, ES
|
| (73) |
Minoryx Therapeutics S.L.,
Av. Ernest Lluch 32, 08302 Mataro , Barcelona,
ES
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | 2,4-Tiazolidindiono dariniai centrinės nervų sistemos sutrikimų gydyme |
| 2,4-THIAZOLIDINEDIONE DERIVATIVES IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS |
| Payment date | Validity (years) | Amount | |
| 2026-03-23 | 12 | 289.00 EUR |
| 2027-04-01 |